Home
overview

The global wearable devices market size is expected to reach a value of $12.1 billion USD by 2021 with time dependent delivery, large volume administration with minimal injection pain and the use of connectivity to enhance user-value being key factors driving the market.

With that in mind, SMi is proud to present Europe's only Wearable Injectors Conference, taking place on the 9th-10th of October 2019, in London.

SMi’s Wearable Injectors conference will explore new technologies and advances of on-body devices for the administration of viscous and large molecule drug delivery, and evaluate the impact of IoT, connectivity and enhancement of user-interface which make up core components within the wearable devices field.

This two-day agenda offers you peer-to-peer networking with Global Device Development Managers, Senior Connectivity Engineers, Leaders in Device Data Generation, Human Factors Directors and many more.

We look forward to welcoming you to the conference in October.
 

 

  • LISTEN to case studies from leading pharmaceutical companies revolutionizing the medical device industry
  • HEAR how on-body injectors are facilitating the administration of time-dependent, large volume and viscous drug delivery
  • ASSESS how connectivity is being used to improve patient adherence, health-monitoring and enhancing the user-interface
  • EXPLORE the compatibility, pain and patient handling considerations projecting wearable devices as the future of drug delivery

 

Who Should Attend
Executives, Directors, VPs, Heads, Principals, Managers of:

  • Drug-delivery developers
  • Autoinjectors
  • Device Engineering
  • Human Factors
  • Scientist
  • Product
  • Injectables
  • Packaging
  • Regulatory Affairs
  • Connectivity
  • Medical Device Data
  • Novel Product Technology
  • Smart device developers
  • Training device developers
  • Device-safety solution providers
  • Drug developers

or anyone who works with Wearable Devices/ On-Body Injectors within pharmaceutical, biotech and solution providers.
 

3P INNOVATION LTD; AbbVie Ltd; addey and stanhope school; Affibody AB; Aptar; APTAR PHARMA; Ascendis Pharma GmbH; Aspen Pharmacare; AstraZeneca; B. Brauná; BA Consultancy; BAUMANN SPRINGS LTD; Bayer Pharma AG; Becton Dickinson; Bespak Innovation; Biocorp; Biopharm Insight; Boehringer Ingelheim; Boehringer Ingelheim GmbH; Cambridge Consultants Ltd; Colwill Health Ltd.; Consillient Health; DATWYLER PHARMA PACKAGING INTERNATIONAL NV; Datwyler Schweiz AG; DTP Holding; E3D ACA Ltd; F. Hoffmann-La Roche Ltd.; Formycon AG; FRUH VERPACKUNGSTECHNIK AG; Galderma; GALDERMA R&D; Genentech, Inc.; Gerresheimer; Glenmark Pharmaceuticals S A; GROUPE JBT; GSK; GSK R&D; Guerbet; Intertek (Schweiz) AG; Laboratoire Aguettant; LEO Pharma; LEO Pharma A/S; LFB Biotechnologies; LRQA; Medical Device Usability Ltd; Merck Group; MET; MHRA; Midatech Pharma; Mikron S A Boudry; MINAKEM SAS; MITSUBISHI GAS CHEMICAL COMPANY, INC; Mylan; Mylan, Inc.; Nemera; New Injection Systems Ltd; Nipro Europe NV; Nolato Medical; Novartis; Novartis Pharma AG; Octapharma; Owen Mumford; Owen Mumford Ltd.; Pfizer; PFIZER CenterOne; Pharmaceutical Systems; Pharmacircle; Pharmis Biofarmaceutica Lda; Phillips-Medisize; Pliva; Roche; Samedan Ltd ; Sandoz; Sanofi S A; Sanofi-Aventis; SCHOTT; SCHOTT AG; SCHOTT Schweiz AG; Shire; SiO2 Medical Products; teamtechnik Maschinen & Anlagen GmbH; Terumo ; Terumo Europe; Terumo Europe N.V.; Terumo Europe NV; Teva-Pliva; TOPAS Advanced Polymers GmbH; Trinseo Deutschland GmbH; UCB; UCB Celltech; Vetter Pharma International GmbH; W.L. Gore & Associates, Inc.; Weidmann Medical Technology AG; West Pharmaceutical Services; West Pharmaceutical Services Deutschland GmbH & Co. KG; Worrell; Ypsomed AG; Zeon Europe GmbH; Zwick Testing Machines Limited;

Conference programme

8:30 Registration & Coffee

9:00 Co-Chairs' Opening Remarks

Anil-Kumar Busimi

Anil-Kumar Busimi, Product Manager, SCHOTT AG
View Bio

Oliver  Shergold

Oliver Shergold, Head of Device Technology, Novartis
View Bio

9:10 An industry outlook to the use of wearable injectors

Oliver  Shergold

Oliver Shergold, Head of Device Technology, Novartis
View Bio

  • Identifying the molecule that requires a wearable device for administration based upon size and time-dependent delivery
  • The business case challenges for new wearable devices
  • An outlook to the future: sustainability and connectivity
  • 9:50 Wearables, connected devices and their roles within clinical trials and patient support ecosystem

    Michael Song

    Michael Song, Sr. Manager, AstraZeneca
    View Bio

    • Explore why connected inhalers have taken hold while connected injectables is slow to take root
    • Understand the role of connected drug delivery device in a digital ecosystem.
    • Selecting off the shelf wearables for clinical trials and watch out points
    • Holistic patient-centric consideration when putting together a digital ecosystem.
     

    10:30 Morning Coffee

    11:00 Care-centred device strategy: Driving better outcomes

    Cedric Gysel

    Cedric Gysel, Healthcare Solutions Manager, Janssen Supply Chain, Johnson & Johnson
    View Bio

    • Care-centred design in the context of combination products
    • Re-thinking the combination product development process
    • Care-centred platform strategies – case studies
     

    11:40 Big problems with big data

    James Whitticase

    James Whitticase, CEO, Cambridge Innovation Limited
    View Bio

  • Compliance not constraint
  • Exception not static
  • Insights from intelligence
  • 12:20 Networking Lunch

    13:20 Closed loop delivery: Thinking further ahead

  • Why now?
  • Where is closed loop delivery appropriate?
  • Patient case
     
  • Maxime Gaillot

    Maxime Gaillot, Senior Device Engineer, Novartis
    View Bio

    Andrew  Warrington

    Andrew Warrington, Project Leader & Patient Advocate, Novartis
    View Bio

    14:00 Collaborating with a pharma company to develop digital therapeutic solutions utilising connected devices

    Digby Harris

    Digby Harris, Global Category Manager, Digital Therapeutics, AstraZeneca
    View Bio

  • The digital therapeutics collaborator ecosystem
  • Key considerations in a connected device development collaboration

     

  • 14:40 Regulation of drug-device combination products (DDC) including wearable injectors

    Veronika Ganeva

    Veronika Ganeva, Senior Quality Assessor, MHRA
    View Bio

    • Introduction to DDC and regulation
    • Regulatory requirements in a changing environment
    • Regulatory challenges
     

    15:20 Afternoon Tea

    15:50 The UK as a Global Testbed for Innovation in Digital Health

    Masood  Ahmed

    Masood Ahmed, Senior Advisor, DigitalHealth
    View Bio

  • An outstanding heritage and culture of invention and innovation
  • The infrastructure is here, including the strength of the NHS, our health data, academic institutions and medical schools
  • The need for innovation is great and the time is now
  • 16:30 Co-Chairs' Closing Remarks and Close of Day One

    Anil-Kumar Busimi

    Anil-Kumar Busimi, Product Manager, SCHOTT AG
    View Bio

    Oliver  Shergold

    Oliver Shergold, Head of Device Technology, Novartis
    View Bio

    8:30 Registration & Coffee

    9:00 Co-Chairs' Opening Remarks

    Oliver  Shergold

    Oliver Shergold, Head of Device Technology, Novartis
    View Bio

    Anil-Kumar Busimi

    Anil-Kumar Busimi, Product Manager, SCHOTT AG
    View Bio

    9:10 Primary packaging solutions for wearable injectors

    Anil-Kumar Busimi

    Anil-Kumar Busimi, Product Manager, SCHOTT AG
    View Bio

  • Key driver - Hospital to home administration for injectable drugs
  • Many biological drugs are highly viscous and pharma companies strive to reduce the number of injections which means increase in the injection volume (> 2ml) ? this can be achieved with new wearable injectors
  • Overview of various wearable injectors platforms are available or in development
  • Cartridges is seen as an ideal primary packaging container for wearable injectors
  • Further advantages with ready to use (RTU) cartridges to shorten the development timeline and time to market.
  • 9:50 Developing Patient Centric Wearable Injection Device

    Min Wei

    Min Wei, Director/Fellow, AstraZeneca
    View Bio

    • User preference for wearable injection device
    • Wearable injection device development for precision medicine
    • Therapeutic effect consideration – dose accuracy and injection related infection
     

    10:30 Morning Coffee

    11:00 Digital wearables – Unlocking the potential of digital to design products for the benefit of the user

    Clare Beddoes

    Clare Beddoes, Senior Medical Innovation and Research Consultant , Cambridge Design Partnership
    View Bio

    • Navigating digital opportunities
    • Designing with three faces
    • The toolkit approach
    • Closing the loop, delivering and monetising benefit
     

    11:40 An outlook of the medical device connectivity landscape

    Jonathan Silver

    Jonathan Silver, Medical Devices and Incidents Manager , St George's University Hospitals NHS Foundation Trust
    View Bio

  • New connectivity projects – how to drive them
  • The solution – a designated connectivity team – and the necessary skillset
  • Challenges of “shadow IT”
  • The St George’s experience 

     

     

     

     

  • 12:20 Networking Lunch

    13:20 Panel Discussion: Defining a medical device – a review of digital health and device regulations

    • The EU MDR
    • What defines a medical device?
    • Stand-alone devices and related software systems
     

    Anil-Kumar Busimi

    Anil-Kumar Busimi, Product Manager, SCHOTT AG
    View Bio

    Min Wei

    Min Wei, Director/Fellow, AstraZeneca
    View Bio

    Bjorg K Hunter

    Bjorg K Hunter, Regulatory Manager, Devices, GSK
    View Bio

    Niall MacLoughlin

    Niall MacLoughlin, Project Consultant, Congenius
    View Bio

    14:00 An industry perspective: The Impact of MDR on Drug-Device Combinations

    Bjorg K Hunter

    Bjorg K Hunter, Regulatory Manager, Devices, GSK
    View Bio

  • Overview of the Impact of MDR on pharma companies
  • Overview of consolidated industry comments to the EMA draft guidance on drug-device combinations
  • How to manage the changing regulatory environment for innovative drug-device combinations such an on body injectors
  • 14:40 Afternoon Tea

    15:10 Launching an Autoinjector under EU-MDR – An expedition into uncharted waters

    Niall MacLoughlin

    Niall MacLoughlin, Project Consultant, Congenius
    View Bio

    • Case study of the development of an integral autoinjector to be launched post-May 2020
    • Planning activities related to obtaining Notified Body opinion
    • Specific changes arising from MDR General Safety and Performance Requirements
    • Summary of other MDR regulatory watchouts and planning considerations
     

    15:50 Co-Chairs' Closing Remarks and Close of Day Two

    Anil-Kumar Busimi

    Anil-Kumar Busimi, Product Manager, SCHOTT AG
    View Bio

    Oliver  Shergold

    Oliver Shergold, Head of Device Technology, Novartis
    View Bio

    +

    FEATURED SPEAKERS

    Anil-Kumar Busimi

    Anil-Kumar Busimi

    Product Manager, SCHOTT AG
    Bjorg K Hunter

    Bjorg K Hunter

    Regulatory Manager, Devices, GSK
    Cedric Gysel

    Cedric Gysel

    Healthcare Solutions Manager, Janssen Supply Chain, Johnson & Johnson
    Digby Harris

    Digby Harris

    Global Category Manager, Digital Therapeutics, AstraZeneca
    James Whitticase

    James Whitticase

    CEO, Cambridge Innovation Limited
    Maxime Gaillot

    Maxime Gaillot

    Senior Device Engineer, Novartis
    Michael Song

    Michael Song

    Sr. Manager, AstraZeneca
    Min Wei

    Min Wei

    Director/Fellow, AstraZeneca
    Niall MacLoughlin

    Niall MacLoughlin

    Project Consultant, Congenius
    Oliver  Shergold

    Oliver Shergold

    Head of Device Technology, Novartis
    Veronika Ganeva

    Veronika Ganeva

    Senior Quality Assessor, MHRA

    Andrew Warrington

    Project Leader & Patient Advocate, Novartis
    Andrew  Warrington

    Andrew is a health hacker and a member the #WeAreNotWaiting open source diabetes care movement. At his day job in the pharma industry, he works on finding ways to generate optimal medical outcomes by combining traditional medicines with digital therapeutics. He studied Creative Arts.

    Anil-Kumar Busimi

    Product Manager, SCHOTT AG
    Anil-Kumar Busimi

    Anil Busimi started his professional career in 2003 at SCHOTT AG in Germany. He worked in different roles including business development, project manager, and consultant in corporate strategy. In 2005, he moved to SCHOTT Pharmaceutical Packaging business and played a key role in building long-term business strategy with sound understanding of market trends, customer needs and competitive landscape. He has more than 10 years experience in product management and innovation. From August 2009 until June 2016, he held various positions in global product management for pre-fillable syringe business including glass and polymer PFS solutions. Currently, he is in the strategy & innovation team as senior global product manager for Cartridges and led the iQ™ Platform market launch. He is a professional speaker at many conferences and seminars on topics related to parenteral primary packaging and drug delivery devices.
    He holds M.Sc. degree in Agriculture and Genetics and a MBA.
     

    Bjorg K Hunter

    Regulatory Manager, Devices, GSK
    Bjorg K Hunter

    Bjorg Hunter holds a BSc in Design and Innovation Engineering from Technical University of Denmark and an MSc in Biomedical Engineering from Aarhus University, Denmark. Bjorg has been with GSK since graduating and has held different roles within the Device Engineering Group. In 2015 Bjorg moved into the late stage parenterals area as device lead for key GSK parenteral devices, working closely with internal GSK project teams and external partners including device development, Human Factors and regulatory compliance. She progressed into leading a device management team in January 2017, where she has had the accountability of project management and regulatory compliance for parenteral devices. In February 2019 Bjorg moved into a key management role in CMC regulatory where she is responsible for the global regulatory and advocacy strategy for GSK’s portfolio of devices across modalities and lifecycle.

    Cedric Gysel

    Healthcare Solutions Manager, Janssen Supply Chain, Johnson & Johnson
    Cedric Gysel

    Cedric is a Healthcare Solutions Manager at Johnson&Johnson Design where he is responsible for Patient Centered Design initiatives supporting Janssens (Pharmaceutical Companies of J&J) R&D and Supply Chain portfolio driving better outcomes and user experience using a care centered approach. He holds a Master in Medical Device Technology from the University of Applied Science at Bern, Switzerland and has more than 10 years of experience in device development and lifecycle management.

    Clare Beddoes

    Senior Medical Innovation and Research Consultant , Cambridge Design Partnership
    Clare Beddoes

    Clare has more than 15 years’ experience of researching and analysing the medical technology, pharma and biotech industry. Her expertise includes unmet needs exploration through structured interviewing and in-depth desk research, commercial due diligence and market strategy. She draws on the experiences of users and key stakeholders to validate applications of existing products and drive innovation of novel products. Her recent projects include investigating potential applications for a newly developed respiratory rate monitor, assessing potential patient profiles and user scenarios for a large-volume injection device concept and determining optimal routes to the UK market for a Korean dental product company.

    Digby Harris

    Global Category Manager, Digital Therapeutics, AstraZeneca
    Digby Harris

    Digby Harris is AstraZeneca’s Global Procurement lead for Digital Therapeutics and has been involved in developing Digital Therapeutics alliances for over 6 years (including connected device development). During that time Digby has also been AstraZeneca’s Global Procurement lead for drug delivery device development. Previously Digby has worked in technology licensing and research collaborations in the Oncology and Respiratory areas.

    James Whitticase

    CEO, Cambridge Innovation Limited
    James Whitticase

    James is a Medtech leader with an international track record of successful start-up, turnaround, mergers and exits. He started out as a software engineer before moving on to study medicine at University College London. He has over 20 years of hands on medical experience that ranges from hospital and primary care through to national and international medical director roles.

    James has a specific interest in device companies working with big data and artificial intelligence solutions internationally. Today James is the CEO at Cambridge Respiratory Innovations Limited who has developed a world first connected hand held big data respiratory device.
     

    Jonathan Silver

    Medical Devices and Incidents Manager , St George's University Hospitals NHS Foundation Trust
    Jonathan Silver

    A clinical scientist and engineer in the NHS since 2011, Jonathan has a wide range of experience across medical device governance, acquisition, connectivity and safety. He has a particular interest in human factors and ensuring that solutions suit clinical workflow, and has provided consultancy to a number of acute providers on achieving effective bedside medical device integration. He is currently the lead for medical device safety and training at St George’s University Hospitals NHS Trust.

    Masood Ahmed

    Senior Advisor, DigitalHealth
    Masood  Ahmed

    Masood has a passion for innovation and a head for strategy. A proven digital leader with a special interest in emerging technologies.With over 20 years’ experience in international healthcare, the NHS and commercial sector, his recent leadership positions include Global Medical Director - Dell Healthcare & Life Sciences, Chief Digital Officer - Health Innovation Network, and Managing Director - Dell Healthcare UK. He also brings unique insights from his experiences in running healthcare start-ups, leading on national negotiations for the BMA, and heading up a Deanery Action Team. He originally trained as a surgeon before becoming a GP, and has worked as a clinician across mental health, primary, and secondary care.
     

    Maxime Gaillot

    Senior Device Engineer, Novartis
    Maxime Gaillot

    Maxime Gaillot works for Novartis since 2018. He has 15 years’ experience in the medical device and polymer industry. After some years, in the plastic closure industry, Maxime started his career in the Medical Device industry at Novartis. He worked on the development of a dual chamber pen injector and an electronic reusable injector. At Roche, as a single mater expert for Needle Safety Device, he supported filing for a Rheumatoid Arthritis treatment and the development of the Needle Safety Training Device. He was the Device Team Leader for several molecules and ad interim Section Head for Device Engineering. Nowadays at Novartis, he is a Senior Project Leader for ocular injection and large volume delivery system, with some interest in closed loop delivery system. Maxime is graduated from the ENSAM Paris in Mechanical Engineering.

    Michael Song

    Sr. Manager, AstraZeneca
    Michael Song

    Michael Song leads the Device Functionality, Safety and Digital Connectivity group at MedImmune, a Member of the AstraZeneca Group. In his current role, he oversees device functionality; primary container science and technology; biocompatibility; container closure integrity testing; and digital connectivity. Prior to his current role, Michael was head of Device and Package Engineering at Adello Biologics, a member of Amneal Pharmaceutical. He also has held key engineering lead and toxicology SME positions at Stryker, Kavlico, and other companies. Michael holds a BS in Electrical Engineering from Purdue University and PhD in Neuroscience and Toxicology from Iowa State University.

    Min Wei

    Director/Fellow, AstraZeneca
    Min Wei

    Min is a Director and Fellow at Astrazeneca. He has over 15 years of drug/device combination product development experience. During this time, he has worked at BD, Eli Lilly and Johnson&Johnson on projects from concept phase through commercialization. His experience spans device engineering, formulation development, process engineering and packaging. Min received his Ph.D. in Materials Science and his MBA from US. His MS degrees are in Biotechnology and Computer Science. Min is an inventor of more than 50 patents and patent applications. He is also a certified Six Sigma Black Belt from American Society for Quality (ASQ).

    Niall MacLoughlin

    Project Consultant, Congenius
    Niall MacLoughlin

    Niall has over 20 years Quality and Regulatory experience with medical devices. For the last 6 years he has been involved with drug-device combination development projects and in recent years focusing on pre-filled syringes and integral auto-injectors. Niall works as a project consultant supplying regulatory and design consultancy expertise to companies involved in drug-device combination development. Niall is experienced in setting up, managing and maintaining complex design history files for drug device development projects and generating, reviewing and approving the associated documentation. Niall is currently focused on a project that involves development of an auto-injector that needs to comply with EU- MDR regulations.

    Oliver Shergold

    Head of Device Technology, Novartis
    Oliver  Shergold

    Dedicated to improving people’s lives through simple, reliable drug delivery devices, Oliver has gained extensive experience of the whole product development life-cycle as well as the industrialisation and maintenance of manufacturing processes. He has worked in a range of companies on innovative medical devices such as needle-free injectors, insulin pumps and high-volume high-viscosity patch injectors. He currently leads a team of device technology experts developing and caring for liquid drug delivery devices at Novartis such as auto-injectors, pen injectors and needle safety devices.

    Veronika Ganeva

    Senior Quality Assessor, MHRA
    Veronika Ganeva

    Veronika is a quality assessor at the MHRA, where she is responsible for the evaluation of a diverse portfolio of biological medicinal products, which includes recombinant and non-recombinant proteins, monoclonal antibodies, plasma-derived products, vaccines, ATMPs and others. She has a PhD degree in Stem Cell and Developmental Biology from the University of Edinburgh and has worked on a range of research and regulatory positions in academia, the pharmaceutical industry and two regulatory agencies. Veronika is passionate about helping bring high quality medicinal products to the market and a fair and science-based regulatory process. She has an additional interest in medical devices and drug-device combination products.

    Sponsors

    Exhibitors

    Official Media Partner

    Supporting Media Partners

    VENUE

    Copthorne Tara Hotel

    Scarsdale Place, Kensington, London, United Kingdom

    The Copthorne Tara Hotel London Kensington is an elegant contemporary four-star hotel in prestigious Kensington, located just a two minutes walk from High Street Kensington underground station, making exploring easy. The hotel offers well-appointed and comfortable guest rooms combining Standard, Superior and Club accommodation. Club rooms offer iconic views over the city and include Club Lounge access for complimentary breakfast and refreshments. Guests can sample the authentic Singaporean, Malaysian and Chinese cuisine at Bugis Street, traditional pub fare at the Brasserie Restaurant & Bar or relax with a delicious drink at West8 Cocktail Lounge & Bar.

    The Copthorne Tara Hotel boasts 745 square meters of flexible meeting space, consisting of the Shannon Suite and the Liffey Suite, ideal for hosting conferences, weddings and social events. Facilities include access to the business centre 24 hours a day, fully equipped fitness room, gift shop, theatre desk and Bureau de Change. With ample onsite parking outside the London congestion charge zone and excellent transport links via Heathrow Airport, the hotel is the perfect location for business or leisure stays. The hotel is within close proximity to the shops of High Street Kensington, Knightsbridge and Westfield London, Olympia Conference Centre, Royal Albert Hall, Kensington Palace and Hyde Park.

     

    A number of our clients have been approached by third party organisations offering to book hotel rooms. We would advise that you do not book through them as they are not representing the SMi Group. SMi Group books all hotel rooms directly. If you are approached by a third party organisation then please contact us before making any bookings. If you have already booked a hotel room using a third party organisation, we would highly recommend contacting the hotel you were booked into to ensure a booking has been made for you. We would also advise you to please check the terms and conditions of the booking carefully.
    HOTEL BOOKING FORM

    Speaker presentation, Davide Mercadante

    Download

    Speaker Presentation, Alexander Zurn

    Download

    Speaker Presentation, Shota Arakawa

    Download

    Chair letter from Anil-Kumar Busimi and Oliver Shergold

    Download

    Speaker Interview with Andreas Caduff

    Download

    Speaker Interview with Maxime Gaillot

    Download

    Preliminary Attendees by Company and Job Title

    Download

    SPEAKER BIOGPRAHI ES

    Download

    Speaker Interview with Oliver Shergold, Novartis

    Download

    Speaker interview with Min Wei, AstraZeneca

    Download

    Workshop Programmes

    Download

    2019 Short Programme

    Download

    2019 Full Programme

    Download

    Sponsors


    Schott AG Pharmaceutical Systems

    Sponsors
    http://www.schott.com/uk/english/index.html

    SCHOTT is a leading international technology group in the areas of specialty glass and glass-ceramics. With more than 130 years of outstanding development, materials and technology expertise we offer a broad portfolio of high-quality products and intelligent solutions that contribute to our customers’ success. SCHOTT Pharmaceutical Systems is one of the world’s leading suppliers of primary packaging and specialized analytical lab services for the pharmaceutical industry. We provide our customers quality solutions while meeting their highest demands with our expertise and broad product portfolio; including ampoules, cartridges, vials and syringes made of glass and COC polymer. Our state-of-the-art production facilities and our products comply with the highest international quality standards for pharmaceutical needs.

    Exhibitors


    Mikron Automation

    Exhibitors
    http://www.mikron.com/automation

    Mikron Automation is your partner for scalable and customized assembly systems – from the first idea to the highest performance solutions. The Automation division has over 700 employees dedicated to design and build your solutions at its 6 sites and support you wherever you are in the world.

    Media Partners


    ONdrugDelivery Magazine

    Official Media Partner
    http://ondrugdelivery.com

    ONdrugDelivery provides 30,000 readers throughout global pharma/biopharma, with the latest, most pertinent industry information and intelligence about the drug delivery-related ideas, technologies, services and products the sector is developing. Established in 2004, and trusted throughout the industry for its high quality contributions from leading drug delivery experts, ONdrugDelivery is a must for pharma / biotech industry professionals who need to know what’s going on in drug delivery. Subscribe online today to the print or free digital edition: www.ondrugdelivery.com/subscribe.

    Media Partners


    Mednous

    Supporting Media Partners
    http://www.MedNous.com

    MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com


    Pharmacircle

    Supporting Media Partners
    http://www.pharmacircle.com

    PharmaCircle is an innovative knowledge management company serving the current and future global leaders in the Pharmaceutical and Biotechnology related industries. PharmaCircle is a one stop information and analysis source for pipeline, products, clinical trials, drug delivery technologies, deals and acquisitions, company financials, venture capital investments, product sales, pharmaceutical services, news, patents and more….


    Technology Networks

    Supporting Media Partners
    http://go.technologynetworks.com/subscribe-to-newsletters

    Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com


    pharmanews hq

    Supporting Media Partners
    http://http://pharmanewshq.com

    MedChemNet provides a unique and unparalleled platform for the medicinal chemistry community to share insights, discuss the latest research, and help move the field forward. MedChemNet covers all aspects of the drug discovery pipeline, from target identification and validation, through computer aided drug design (CADD), synthesis, screening and other biophysical techniques, to development of novel lead compounds and pre-clinical in vivo proof of concept. We also cover the design of synthetic drug delivery carriers and ADME/toxicology studies, as well as intellectual property and economic related issues. Website: Welcome to Pharma News HQ, the journal dedicated to the pharmaceutical and biopharmaceutical contract services. With regular sections on contract manufacturing, contract research, contract packaging, formulation/development services, contract analytical testing, APIs, stability testing, clinical research and other areas, we bring the most complete coverage of trends and issues in the industry. Pharmanewshq.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production.


    Farmavita

    Supporting Media Partners
    https://farmavitar.com

    FarmavitaR+ is the professional network of experts and service providers. Network is gathering local consultants from 90 countries in Europe, Asia, North America, Latin America, Australia and Africa. Management of international, multi-centre projects is our core competence. FarmavitaR+ is providing solutions related to pharmaceutical, medical device, food supplement and cosmetic products. Scope of services is related to solutions for product development, quality assurance, clinical trials, product registration, portfolio analysis, lifecycle management, vigilance/risk management, pricing/reimbursing, market access and promotional compliance. FarmavitaR+ is brand name of Farmavita Regulanet Ltd. Visit https://farmavitar.com for more information. Outsource anything you can think of!


    Pharmalicensing

    Supporting Media Partners
    http://www.pharmalicensing.com

    Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique online Showcase Profiling & Discover services, as well as its renowned Partnering Search service leveraging its global network of industry experts, to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing is actively utilized by many tens of thousands of industry professionals each month. Pharmalicensing is a division of Cognis Group, Inc


    Pharmavision

    Supporting Media Partners
    http://www.pharmavision.co.uk

    PharmaVision offers a consultancy service providing independent pharmaceutical thematic research to the healthcare industry, the investment community and competitive intelligence specialists. We perform due diligence research and provide expert commentary in healthcare. Our reports combine scientific analysis in drug delivery, R&D technologies and pharmaceutical products including patient modelling, product/technology forecasts and market trends evaluation.


    Drug Discovery Today

    Supporting Media Partners
    http://www.drugdiscoverytoday.com/

    Drug Discovery Today covers the whole of the preclinical drug discovery process. The reviews are cutting edge, written by experts in their respective fields and cover all aspects of drug discovery from genomic and proteomic approaches, computational drug design, medicinal chemistry and the translation of these sciences to therapies.


    Pharma Journalist

    Supporting Media Partners
    http://www.pharmajournalist.com

    Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry. Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry. Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.


    pharmaphorum

    Supporting Media Partners
    http://www.pharmaphorum.com

    pharmaphorum drives innovation within the pharmaceutical industry, by bringing healthcare together through a suite of media services that help produce and disseminate thought leadership, combined with an online platform for communicating messages to a global audience.Visit www.pharmaphorum.com


    Pharmaceutical Technology

    Supporting Media Partners
    http://www.pharmaceutical-technology.com

    Pharmaceutical-technology.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production. Pharmaceutical-technology.com brings you the latest in industry projects and updates, along with the news, views and trends that leading professionals – from senior executives to manufacturing managers and heads of procurement – require to stay on top of their field.

    SAVE TO


    Outlook Calendar  OUTLOOK CALENDAR
    Google Calendar  GOOGLE CALENDAR
    ICal Calendar  ICAL CALENDAR
    Yahoo! Calendar  YAHOO! CALENDAR

    Copthorne Tara Hotel

    Scarsdale Place
    Kensington
    London W8 5SR
    United Kingdom

    Copthorne Tara Hotel

    The Copthorne Tara Hotel London Kensington is an elegant contemporary four-star hotel in prestigious Kensington, located just a two minutes walk from High Street Kensington underground station, making exploring easy. The hotel offers well-appointed and comfortable guest rooms combining Standard, Superior and Club accommodation. Club rooms offer iconic views over the city and include Club Lounge access for complimentary breakfast and refreshments. Guests can sample the authentic Singaporean, Malaysian and Chinese cuisine at Bugis Street, traditional pub fare at the Brasserie Restaurant & Bar or relax with a delicious drink at West8 Cocktail Lounge & Bar.

    The Copthorne Tara Hotel boasts 745 square meters of flexible meeting space, consisting of the Shannon Suite and the Liffey Suite, ideal for hosting conferences, weddings and social events. Facilities include access to the business centre 24 hours a day, fully equipped fitness room, gift shop, theatre desk and Bureau de Change. With ample onsite parking outside the London congestion charge zone and excellent transport links via Heathrow Airport, the hotel is the perfect location for business or leisure stays. The hotel is within close proximity to the shops of High Street Kensington, Knightsbridge and Westfield London, Olympia Conference Centre, Royal Albert Hall, Kensington Palace and Hyde Park.

     

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SMi.
    Full details of our privacy policy can be found here https://www.smi-online.co.uk/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data@smi-online.co.uk.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smi-online.co.uk/opt-out